Signpost Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$9.18M |
| 2 |
CPN
Calpine Corporation
CPN
|
+$4.64M |
| 3 |
SRG
Seritage Growth Properties
SRG
|
+$4.02M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$3.07M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.7M |
| 2 |
Ecolab
ECL
|
+$13.1M |
| 3 |
Equinix
EQIX
|
+$7.45M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$5.31M |
| 5 |
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
|
+$3.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.32% |
| 2 | Consumer Discretionary | 12.54% |
| 3 | Utilities | 11.44% |
| 4 | Healthcare | 10.25% |
| 5 | Industrials | 9.46% |
Similar funds
Signpost Capital Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Signpost Capital Advisors held 26 positions worth $214M, down 43% from $373M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Signpost Capital Advisors withdrew a net $21.8M in Q1 2016, closing 7 positions and reducing 5 holdings. Its most notable exit was Allergan plc, an estimated $18.7M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Utilities.
Against the trend, Signpost Capital Advisors opened a new position in Pfizer worth $9.03M.
- Signpost Capital Advisors's largest Q1 2016 buy was Pfizer: 321,221 shares worth $9.03M.
- Signpost Capital Advisors added most to Calpine Corporation in Q1 2016, an estimated $4.64M increase.
- Signpost Capital Advisors's biggest Q1 2016 reduction was IMS HEALTH HLDGS INC COM STK (DE), cutting an estimated $3.59M.
- Signpost Capital Advisors fully exited Allergan plc in Q1 2016, selling an estimated $18.7M.
- Signpost Capital Advisors's ten largest holdings make up 79% of its $214M portfolio in Q1 2016.
- Signpost Capital Advisors opened 3 new positions and closed 7 in Q1 2016.
- Signpost Capital Advisors's portfolio value fell 43% quarter-over-quarter to $214M.
Based on Signpost Capital Advisors's 13F filing for Q1 2016, filed 13 May 2016.